Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03 on Revenues of $11.6M

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03. Revenue for the quarter came in at $11.6 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform